Alkermes' depression treatment fails to get FDA panel backing
Alkermes CEO nets $3.5M in stock sales since April - Boston Business Journal
Life Science Leader May 2019
Richard Pops, chief executive officer of Alkermes Plc, speaks during... News Photo - Getty Images
Blood-Brain Barrier Booming As A Source Of New Biotechnology Research Challenges | The Scientist Magazine®
Tweet To The Chief
Fb Img 1482691516847 - Gallery - Richard "Pops" Rumley | racersreunion.com
Alkermes CEO: Our opioid addiction treatment has 'best days' ahead
Alkermes expands pipeline, launches Phase 2 trial - Boston Business Journal
Alkermes stock climbs on positive test results for antidepressant - The Boston Globe
Alkermes' Richard Pops On Always Looking Forward
6 Things You Might Not Know About Richard Pops CEO Of Alkermes
Fighting the Opioid Epidemic- Richard Pops, Alkermes Chairman and CEO - YouTube
256 | Iron History with Richard "Pops" Sorin • Zach Even-Esh
Alkermes looks to schizophrenia drug approval as sales jump 24%
Alkermes Inspiration Grants® | Alkermes
Richard "Pops" J. Fontaine, Sr. Obituary - Visitation & Funeral Information
Sir Cliff Richard pops in to charity fund-raiser - Manchester Evening News
Alkermes Has Launched Employee Resource Groups | News Direct
Richard Pops CEO Alkermes Interview | kvue.com
Richard "Pops" Smith Kidney Campaign - Home | Facebook
Moving From Crisis To Lasting Change
Richard “Pops” Gonzales | Obituaries | riograndesun.com
